Why the study?
Is the ACE I/D polymorphism associated with susceptibility to Alzheimer's disease in Slovak Caucasians?
Is the ACE I/D polymorphism associated with susceptibility to Alzheimer's disease in Slovak Caucasians?
The combination of ACE DD genotype and APOE*E4 allele significantly increases the risk of sporadic Alzheimer's disease in Slovak Caucasians.
Answers are grounded in this paper and cite their sources.
ACE DD plus APOE*E4 was associated with increased AD risk; leaves open value of genotyping for risk stratification or prevention.
Angiotensin-converting enzyme (ACE) has been reported to show altered activity in patients with neurological diseases. The recent studies found that a 287 bp insertion/deletion (I/D) polymorphism of the ACE gene may be associated with susceptibility to Alzheimer’s disease (AD) but the results have been heterogenous between studies in Europe. In the present study we examined for the first time the association of ACE I/D polymorphism along with APOE genotype in 70 sporadic AD and 126 control subjects in Slovak Caucasians (Central Europe). An increased risk for AD was observed in subjects with at least one APOE*E4 allele (OR=3.99, 95% CI=1.97–8.08). No significant differences for the genotype distribution or the allele frequency were revealed comparing controls and patients for ACE gene. Gene-gene interaction analysis showed increase of the risk to develop AD in subjects carrying both the ACE DD genotype and the APOE*E4 allele (OR=10.32, 95% C.I. 2.67–39.81).
No takes yet. Share an insight, caveat, or question.
Trebuňová et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: